Search Results
Results found for "GPCR assay development"
- Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of ...
These molecules are then evaluated at unprecedented speed and scale on hundreds of GPCR targets simultaneously Read more at the source #DrGPCR #GPCR #IndustryNews
- ShouTi Pharma CEO Dr. Raymond Stevens was interviewed by Moira Gunn of the NPR TechNation podcast
April 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
- Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
CFTX-1554 For The Treatment Of Neuropathic Pain "— Confo’s first drug candidate moves into clinical development – Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs CFTX-1554 is being developed as a non-opioid approach to the treatment of neuropathic pain, a debilitating pharmacokinetics of CFTX-1554 in healthy subjects (NCT05260658). " Read more at the source #DrGPCR #GPCR
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel Read more at the source #DrGPCR #GPCR #IndustryNews
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
(Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development Read more at the source #DrGPCR #GPCR #IndustryNews
- John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist
control neuropsychiatric symptoms in conditions such as schizophrenia. " Read more at the source #DrGPCR #GPCR
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Read more at the source #DrGPCR #GPCR #IndustryNews
- Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
(Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares reported its FY2021 financial result and provided an update on operational activities
February 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Kenakin walks through this as a living system , showing how GPCRs exist in multiple conformations and This has immediate implications for interpreting EC50 shifts, partial agonism, and assay readouts—especially The result is not just cleaner assay design but a sharper decision framework for selecting, prioritizing lets you predict safety margins, dose–response behavior, and translational risk before they derail development GPCR members save 50%+ (check your Weekly News code).
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- ShouTi Pharma has a brand new website
"We are an experienced, innovative, global team on a bold mission to improve health by creating and developing Read more at the source #DrGPCR #GPCR #IndustryNews
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Biotechnology, a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs OB-004 is a GPCR targeted protein analog of CCL2 that targets the CCR2 receptor. Read more at the source #DrGPCR #GPCR #IndustryNews
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
December 2021 "30/11/2021 Confo will work together with Regeneron to apply its GPCR drug discovery platform technology platform, which uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs enabling the discovery of novel therapeutic antibody drug candidates. " Read more at the source #DrGPCR #GPCR
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
royalty on net sales in China CHESTERBROOK, Pa., Jan. 27, 2022 A biopharmaceutical company focused on the development Read more at the source #DrGPCR #GPCR #IndustryNews
- Learn more about Neurocrine Biosciences with their new video
Read more at the source #DrGPCR #GPCR #IndustryNews
- Newly launched antibody libraries put hard-to-drug targets within reach
Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics To target hard-to-drug targets like G protein-coupled receptors (GPCRs), more libraries, including better Read more at the source #DrGPCR #GPCR #IndustryNews
- Conjugation Strategies for Probe Development
This conjugation is very useful for tagging biomolecules and can also be used to develop fluorescent Chapter Three - Bioconjugated Materials in the Development of Subunit Vaccines.
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
GPCR so powerful. “We don’t just deliver compounds, we solve assay problems.” — Dr. Maria Majellaro Celtarys specializes in the custom development of fluorescent ligands using a modular Democratize access to high-performance chemical probes and make assay development faster, cheaper, and data platform , fluorescent ligands , assay development , GPCR research community , Dr. GPCR ecosystem , GPCR webinar series
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute Read more at the source #DrGPCR #GPCR #IndustryNews
- Dr. Alexander S. Hauser receives the Bachem award for peptide science
November 2021 Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel Read more at the source #DrGPCR #GPCR #IndustryNews
- Dr. Thomas P. Sakmar receives an honorary doctorate from Karolinska Institute
Read more at the source #DrGPCR #GPCR #IndustryNews
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the Read more at the source #DrGPCR #GPCR #IndustryNews
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric Read more at the source #DrGPCR #GPCR #IndustryNews
